nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—Cranial nerve paralysis—Vincristine—muscle cancer	0.16	0.182	CcSEcCtD
Mepivacaine—Cranial nerve paralysis—Methotrexate—muscle cancer	0.0776	0.0882	CcSEcCtD
Mepivacaine—Meningism—Methotrexate—muscle cancer	0.0515	0.0586	CcSEcCtD
Mepivacaine—Paralysis—Vincristine—muscle cancer	0.0265	0.0302	CcSEcCtD
Mepivacaine—Apnoea—Etoposide—muscle cancer	0.0176	0.02	CcSEcCtD
Mepivacaine—Paralysis—Methotrexate—muscle cancer	0.0129	0.0146	CcSEcCtD
Mepivacaine—Urinary retention—Vincristine—muscle cancer	0.0127	0.0145	CcSEcCtD
Mepivacaine—Cardiac arrest—Vincristine—muscle cancer	0.0127	0.0145	CcSEcCtD
Mepivacaine—Swelling—Etoposide—muscle cancer	0.0123	0.014	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Etoposide—muscle cancer	0.0112	0.0127	CcSEcCtD
Mepivacaine—Paralysis—Doxorubicin—muscle cancer	0.0111	0.0127	CcSEcCtD
Mepivacaine—Apnoea—Methotrexate—muscle cancer	0.0105	0.012	CcSEcCtD
Mepivacaine—Ventricular arrhythmia—Doxorubicin—muscle cancer	0.0105	0.0119	CcSEcCtD
Mepivacaine—Cardiac arrest—Etoposide—muscle cancer	0.0103	0.0117	CcSEcCtD
Mepivacaine—Sweating—Vincristine—muscle cancer	0.00988	0.0112	CcSEcCtD
Mepivacaine—Chills—Dactinomycin—muscle cancer	0.00929	0.0106	CcSEcCtD
Mepivacaine—Sweating increased—Etoposide—muscle cancer	0.00912	0.0104	CcSEcCtD
Mepivacaine—Erythema—Dactinomycin—muscle cancer	0.00902	0.0103	CcSEcCtD
Mepivacaine—SCN4A—renal system—muscle cancer	0.00854	0.0706	CbGeAlD
Mepivacaine—Atrioventricular block—Doxorubicin—muscle cancer	0.00798	0.00908	CcSEcCtD
Mepivacaine—Back pain—Vincristine—muscle cancer	0.00779	0.00886	CcSEcCtD
Mepivacaine—SCN9A—tendon—muscle cancer	0.00748	0.0618	CbGeAlD
Mepivacaine—Agitation—Vincristine—muscle cancer	0.0074	0.00842	CcSEcCtD
Mepivacaine—Oedema—Dactinomycin—muscle cancer	0.00736	0.00837	CcSEcCtD
Mepivacaine—SCN8A—head—muscle cancer	0.00729	0.0603	CbGeAlD
Mepivacaine—SCN8A—testis—muscle cancer	0.00704	0.0582	CbGeAlD
Mepivacaine—Convulsion—Vincristine—muscle cancer	0.00698	0.00794	CcSEcCtD
Mepivacaine—Hypertension—Vincristine—muscle cancer	0.00695	0.00791	CcSEcCtD
Mepivacaine—Chills—Etoposide—muscle cancer	0.00673	0.00765	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00671	0.00763	CcSEcCtD
Mepivacaine—SCN4A—tendon—muscle cancer	0.00667	0.0551	CbGeAlD
Mepivacaine—SCN3A—renal system—muscle cancer	0.00665	0.0549	CbGeAlD
Mepivacaine—Anaphylactic shock—Vincristine—muscle cancer	0.00657	0.00748	CcSEcCtD
Mepivacaine—Oedema—Vincristine—muscle cancer	0.00657	0.00748	CcSEcCtD
Mepivacaine—Hyperhidrosis—Vincristine—muscle cancer	0.00636	0.00723	CcSEcCtD
Mepivacaine—Back pain—Etoposide—muscle cancer	0.00631	0.00718	CcSEcCtD
Mepivacaine—SCN9A—testis—muscle cancer	0.00619	0.0512	CbGeAlD
Mepivacaine—Hypotension—Vincristine—muscle cancer	0.00614	0.00699	CcSEcCtD
Mepivacaine—SCN5A—cardiac atrium—muscle cancer	0.00593	0.0491	CbGeAlD
Mepivacaine—Paraesthesia—Vincristine—muscle cancer	0.0059	0.00672	CcSEcCtD
Mepivacaine—Body temperature increased—Dactinomycin—muscle cancer	0.00582	0.00662	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00581	0.00661	CcSEcCtD
Mepivacaine—Loss of consciousness—Etoposide—muscle cancer	0.00574	0.00652	CcSEcCtD
Mepivacaine—SCN4A—head—muscle cancer	0.00572	0.0473	CbGeAlD
Mepivacaine—Convulsion—Etoposide—muscle cancer	0.00565	0.00643	CcSEcCtD
Mepivacaine—Hypertension—Etoposide—muscle cancer	0.00563	0.00641	CcSEcCtD
Mepivacaine—SCN4A—testis—muscle cancer	0.00552	0.0456	CbGeAlD
Mepivacaine—SCN1A—head—muscle cancer	0.00551	0.0456	CbGeAlD
Mepivacaine—SCN2A—vagina—muscle cancer	0.00548	0.0453	CbGeAlD
Mepivacaine—Hypersensitivity—Dactinomycin—muscle cancer	0.00542	0.00617	CcSEcCtD
Mepivacaine—Cardiac arrest—Doxorubicin—muscle cancer	0.00534	0.00608	CcSEcCtD
Mepivacaine—Anaphylactic shock—Etoposide—muscle cancer	0.00533	0.00606	CcSEcCtD
Mepivacaine—Asthenia—Dactinomycin—muscle cancer	0.00528	0.00601	CcSEcCtD
Mepivacaine—Tachycardia—Etoposide—muscle cancer	0.0052	0.00591	CcSEcCtD
Mepivacaine—Body temperature increased—Vincristine—muscle cancer	0.0052	0.00591	CcSEcCtD
Mepivacaine—SCN3A—tendon—muscle cancer	0.00519	0.0429	CbGeAlD
Mepivacaine—Hyperhidrosis—Etoposide—muscle cancer	0.00515	0.00586	CcSEcCtD
Mepivacaine—SCN2A—head—muscle cancer	0.00506	0.0418	CbGeAlD
Mepivacaine—SCN3A—bone marrow—muscle cancer	0.00502	0.0415	CbGeAlD
Mepivacaine—Drowsiness—Methotrexate—muscle cancer	0.005	0.00569	CcSEcCtD
Mepivacaine—Hypotension—Etoposide—muscle cancer	0.00498	0.00566	CcSEcCtD
Mepivacaine—SCN10A—head—muscle cancer	0.00488	0.0403	CbGeAlD
Mepivacaine—Hypersensitivity—Vincristine—muscle cancer	0.00484	0.00551	CcSEcCtD
Mepivacaine—SCN3A—vagina—muscle cancer	0.00481	0.0398	CbGeAlD
Mepivacaine—SCN5A—vagina—muscle cancer	0.0048	0.0397	CbGeAlD
Mepivacaine—Sweating—Methotrexate—muscle cancer	0.00479	0.00545	CcSEcCtD
Mepivacaine—Paraesthesia—Etoposide—muscle cancer	0.00478	0.00544	CcSEcCtD
Mepivacaine—Somnolence—Etoposide—muscle cancer	0.00473	0.00539	CcSEcCtD
Mepivacaine—Asthenia—Vincristine—muscle cancer	0.00472	0.00537	CcSEcCtD
Mepivacaine—Vomiting—Dactinomycin—muscle cancer	0.00468	0.00532	CcSEcCtD
Mepivacaine—SCN3A—head—muscle cancer	0.00445	0.0368	CbGeAlD
Mepivacaine—SCN5A—head—muscle cancer	0.00443	0.0366	CbGeAlD
Mepivacaine—Nausea—Dactinomycin—muscle cancer	0.00437	0.00497	CcSEcCtD
Mepivacaine—Dizziness—Vincristine—muscle cancer	0.00435	0.00495	CcSEcCtD
Mepivacaine—Drowsiness—Doxorubicin—muscle cancer	0.00433	0.00493	CcSEcCtD
Mepivacaine—SCN3A—testis—muscle cancer	0.0043	0.0355	CbGeAlD
Mepivacaine—Urticaria—Etoposide—muscle cancer	0.00423	0.00481	CcSEcCtD
Mepivacaine—Body temperature increased—Etoposide—muscle cancer	0.00421	0.00479	CcSEcCtD
Mepivacaine—Tinnitus—Methotrexate—muscle cancer	0.00419	0.00476	CcSEcCtD
Mepivacaine—Vomiting—Vincristine—muscle cancer	0.00418	0.00476	CcSEcCtD
Mepivacaine—Sweating—Doxorubicin—muscle cancer	0.00415	0.00472	CcSEcCtD
Mepivacaine—Headache—Vincristine—muscle cancer	0.00412	0.00469	CcSEcCtD
Mepivacaine—Chills—Methotrexate—muscle cancer	0.00403	0.00458	CcSEcCtD
Mepivacaine—Bradycardia—Doxorubicin—muscle cancer	0.00396	0.0045	CcSEcCtD
Mepivacaine—Hypersensitivity—Etoposide—muscle cancer	0.00392	0.00446	CcSEcCtD
Mepivacaine—Erythema—Methotrexate—muscle cancer	0.00391	0.00445	CcSEcCtD
Mepivacaine—Nausea—Vincristine—muscle cancer	0.0039	0.00444	CcSEcCtD
Mepivacaine—Asthenia—Etoposide—muscle cancer	0.00382	0.00435	CcSEcCtD
Mepivacaine—Back pain—Methotrexate—muscle cancer	0.00378	0.0043	CcSEcCtD
Mepivacaine—Pruritus—Etoposide—muscle cancer	0.00377	0.00429	CcSEcCtD
Mepivacaine—Vision blurred—Methotrexate—muscle cancer	0.00368	0.00419	CcSEcCtD
Mepivacaine—Tinnitus—Doxorubicin—muscle cancer	0.00362	0.00412	CcSEcCtD
Mepivacaine—Dizziness—Etoposide—muscle cancer	0.00352	0.00401	CcSEcCtD
Mepivacaine—Chills—Doxorubicin—muscle cancer	0.00349	0.00397	CcSEcCtD
Mepivacaine—Convulsion—Methotrexate—muscle cancer	0.00339	0.00385	CcSEcCtD
Mepivacaine—Vomiting—Etoposide—muscle cancer	0.00339	0.00385	CcSEcCtD
Mepivacaine—Erythema—Doxorubicin—muscle cancer	0.00338	0.00385	CcSEcCtD
Mepivacaine—Headache—Etoposide—muscle cancer	0.00334	0.0038	CcSEcCtD
Mepivacaine—Tension—Doxorubicin—muscle cancer	0.00332	0.00378	CcSEcCtD
Mepivacaine—Nervousness—Doxorubicin—muscle cancer	0.00329	0.00374	CcSEcCtD
Mepivacaine—Back pain—Doxorubicin—muscle cancer	0.00327	0.00372	CcSEcCtD
Mepivacaine—Anaphylactic shock—Methotrexate—muscle cancer	0.00319	0.00363	CcSEcCtD
Mepivacaine—Vision blurred—Doxorubicin—muscle cancer	0.00319	0.00363	CcSEcCtD
Mepivacaine—Nausea—Etoposide—muscle cancer	0.00316	0.0036	CcSEcCtD
Mepivacaine—Agitation—Doxorubicin—muscle cancer	0.00311	0.00354	CcSEcCtD
Mepivacaine—Hyperhidrosis—Methotrexate—muscle cancer	0.00308	0.00351	CcSEcCtD
Mepivacaine—Syncope—Doxorubicin—muscle cancer	0.00304	0.00345	CcSEcCtD
Mepivacaine—Hypotension—Methotrexate—muscle cancer	0.00298	0.00339	CcSEcCtD
Mepivacaine—Loss of consciousness—Doxorubicin—muscle cancer	0.00297	0.00338	CcSEcCtD
Mepivacaine—Convulsion—Doxorubicin—muscle cancer	0.00293	0.00334	CcSEcCtD
Mepivacaine—Hypertension—Doxorubicin—muscle cancer	0.00292	0.00332	CcSEcCtD
Mepivacaine—Anxiety—Doxorubicin—muscle cancer	0.00287	0.00327	CcSEcCtD
Mepivacaine—Paraesthesia—Methotrexate—muscle cancer	0.00286	0.00326	CcSEcCtD
Mepivacaine—Somnolence—Methotrexate—muscle cancer	0.00284	0.00323	CcSEcCtD
Mepivacaine—Oedema—Doxorubicin—muscle cancer	0.00276	0.00314	CcSEcCtD
Mepivacaine—Anaphylactic shock—Doxorubicin—muscle cancer	0.00276	0.00314	CcSEcCtD
Mepivacaine—Shock—Doxorubicin—muscle cancer	0.00272	0.00309	CcSEcCtD
Mepivacaine—Tachycardia—Doxorubicin—muscle cancer	0.0027	0.00307	CcSEcCtD
Mepivacaine—Hyperhidrosis—Doxorubicin—muscle cancer	0.00267	0.00304	CcSEcCtD
Mepivacaine—Hypotension—Doxorubicin—muscle cancer	0.00258	0.00294	CcSEcCtD
Mepivacaine—Urticaria—Methotrexate—muscle cancer	0.00253	0.00288	CcSEcCtD
Mepivacaine—Body temperature increased—Methotrexate—muscle cancer	0.00252	0.00287	CcSEcCtD
Mepivacaine—Paraesthesia—Doxorubicin—muscle cancer	0.00248	0.00282	CcSEcCtD
Mepivacaine—Somnolence—Doxorubicin—muscle cancer	0.00246	0.00279	CcSEcCtD
Mepivacaine—Hypersensitivity—Methotrexate—muscle cancer	0.00235	0.00267	CcSEcCtD
Mepivacaine—Asthenia—Methotrexate—muscle cancer	0.00229	0.0026	CcSEcCtD
Mepivacaine—Pruritus—Methotrexate—muscle cancer	0.00226	0.00257	CcSEcCtD
Mepivacaine—Urticaria—Doxorubicin—muscle cancer	0.00219	0.0025	CcSEcCtD
Mepivacaine—Body temperature increased—Doxorubicin—muscle cancer	0.00218	0.00248	CcSEcCtD
Mepivacaine—Dizziness—Methotrexate—muscle cancer	0.00211	0.0024	CcSEcCtD
Mepivacaine—Hypersensitivity—Doxorubicin—muscle cancer	0.00204	0.00232	CcSEcCtD
Mepivacaine—Vomiting—Methotrexate—muscle cancer	0.00203	0.00231	CcSEcCtD
Mepivacaine—Headache—Methotrexate—muscle cancer	0.002	0.00227	CcSEcCtD
Mepivacaine—Asthenia—Doxorubicin—muscle cancer	0.00198	0.00225	CcSEcCtD
Mepivacaine—Pruritus—Doxorubicin—muscle cancer	0.00195	0.00222	CcSEcCtD
Mepivacaine—Nausea—Methotrexate—muscle cancer	0.00189	0.00216	CcSEcCtD
Mepivacaine—Dizziness—Doxorubicin—muscle cancer	0.00183	0.00208	CcSEcCtD
Mepivacaine—Vomiting—Doxorubicin—muscle cancer	0.00176	0.002	CcSEcCtD
Mepivacaine—Headache—Doxorubicin—muscle cancer	0.00173	0.00197	CcSEcCtD
Mepivacaine—Nausea—Doxorubicin—muscle cancer	0.00164	0.00187	CcSEcCtD
